{"id": "1367101576003813379", "creation": 1614777389.0, "user_id": "1113747196099399680", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}}, "text": "#CoronaVaccine | Phase 3 clinical trial results of #Covaxin showed an efficacy of 81% in those without prior infection after a second dose, the company said in a statement.\n\nCovaxin co-developed by Hyderabad-based @BharatBiotech and ICMR.\n\n#COVID19 #CoronaVirusUpdates #vaccine https://t.co/rTODGP7kCj", "first_save": 1634559108.199414, "hashtags": ["#CORONAVACCINE", "#COVAXIN", "#COVID19", "#CORONAVIRUSUPDATES", "#VACCINE"]}